• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性胸膜实质纤维弹性组织增生症的诊断标准:一项提议。

Criteria for the diagnosis of idiopathic pleuroparenchymal fibroelastosis: A proposal.

作者信息

Watanabe Kentaro, Ishii Hiroshi, Kiyomi Fumiaki, Terasaki Yasuhiro, Hebisawa Akira, Kawabata Yoshinori, Johkoh Takeshi, Sakai Fumikazu, Kondoh Yasuhiro, Inoue Yoshikazu, Azuma Arata, Suda Takafumi, Ogura Takashi, Inase Naohiko, Homma Sakae

机构信息

General Medical Research Center, Fukuoka University School of Medicine, 814-0180 Fukuoka, Japan.

Department of Respiratory Medicine, Fukuoka University Hospital, Fukuoka, Japan.

出版信息

Respir Investig. 2019 Jul;57(4):312-320. doi: 10.1016/j.resinv.2019.02.007. Epub 2019 Apr 10.

DOI:10.1016/j.resinv.2019.02.007
PMID:30981683
Abstract

BACKGROUND

Physicians have few opportunities to perform surgical lung biopsy (SLB) to diagnose idiopathic pleuroparenchymal fibroelastosis (IPPFE). Therefore, diagnostic criteria for IPPFE that do not require SLB must be established. Herein, we propose diagnostic criteria for IPPFE with and without SLB.

METHODS AND RESULTS

The diagnostic criteria for IPPFE with SLB are histological, based on computed tomography (CT) lesions compatible with PPFE, predominantly in the upper lobes. The three diagnostic criteria for IPPFE without SLB are as follows: (1) radiologically possible IPPFE (a radiological criterion confirming CT lesions in both lung apexes, regardless of the lower lobe lesions); (2) radiologically probable IPPFE (also a radiological criterion, but mandatory to confirm chest radiograph findings of bilateral upward shift of the hilar structures and/or CT findings of volume loss of the upper lobes); (3) radiologically and physiologically probable IPPFE. Our data from 41 patients with IPPFE and 97 with idiopathic pulmonary fibrosis (IPF) showed that the percentage of the predicted values of the ratio of residual volume to total lung capacity (RV/TLC %pred.) ≥115% and body mass index (BMI) ≤20 kg/m plus RV/TLC %pred. ≥80% performed well for discriminating IPPFE from IPF. These parameters were thus added to criterion (3).

CONCLUSIONS

We have proposed diagnostic criteria for IPPFE in patients with and without SLB. Both imaging criteria and physiological criteria using RV/TLC and BMI successfully discriminate IPPFE from chronic IIPs when SLB cannot be performed.

摘要

背景

医生很少有机会通过手术肺活检(SLB)来诊断特发性胸膜肺实质纤维弹性组织增生症(IPPFE)。因此,必须建立无需SLB的IPPFE诊断标准。在此,我们提出了有或无SLB情况下的IPPFE诊断标准。

方法与结果

有SLB时IPPFE的诊断标准基于组织学,依据与胸膜肺实质纤维弹性组织增生症(PPFE)相符的计算机断层扫描(CT)病变,主要位于上叶。无SLB时IPPFE的三项诊断标准如下:(1)放射学上可能的IPPFE(一项放射学标准,确认双侧肺尖有CT病变,无论下叶病变情况);(2)放射学上很可能的IPPFE(也是一项放射学标准,但必须确认胸部X线片显示肺门结构双侧上移以及/或者CT显示上叶容积缩小);(3)放射学和生理学上很可能的IPPFE。我们对41例IPPFE患者和97例特发性肺纤维化(IPF)患者的数据显示,残气量与肺总量比值(RV/TLC %pred.)≥115%且体重指数(BMI)≤20 kg/m²加上RV/TLC %pred.≥80%的预测值百分比在区分IPPFE与IPF方面表现良好。因此这些参数被添加到标准(3)中。

结论

我们提出了有或无SLB情况下IPPFE患者的诊断标准。当无法进行SLB时,使用RV/TLC和BMI的影像学标准和生理学标准都能成功区分IPPFE与慢性间质性肺疾病(IIP)。

相似文献

1
Criteria for the diagnosis of idiopathic pleuroparenchymal fibroelastosis: A proposal.特发性胸膜实质纤维弹性组织增生症的诊断标准:一项提议。
Respir Investig. 2019 Jul;57(4):312-320. doi: 10.1016/j.resinv.2019.02.007. Epub 2019 Apr 10.
2
Quantitative analysis of lung elastic fibers in idiopathic pleuroparenchymal fibroelastosis (IPPFE): comparison of clinical, radiological, and pathological findings with those of idiopathic pulmonary fibrosis (IPF).特发性胸膜肺实质纤维弹性组织增生症(IPPFE)中肺弹性纤维的定量分析:临床、影像学和病理结果与特发性肺纤维化(IPF)的比较
BMC Pulm Med. 2014 May 28;14:91. doi: 10.1186/1471-2466-14-91.
3
Clinical significance of lower-lobe interstitial lung disease on high-resolution computed tomography in patients with idiopathic pleuroparenchymal fibroelastosis.特发性胸膜肺弹力纤维增生症患者高分辨率 CT 下肺下叶间质病变的临床意义。
Respir Med. 2019 Jul-Aug;154:122-126. doi: 10.1016/j.rmed.2019.06.018. Epub 2019 Jun 20.
4
Physiological Criteria Are Useful for the Diagnosis of Idiopathic Pleuroparenchymal Fibroelastosis.生理标准对特发性胸膜实质纤维弹性组织增生症的诊断有用。
J Clin Med. 2020 Nov 22;9(11):3761. doi: 10.3390/jcm9113761.
5
Evaluation of urinary desmosines as a noninvasive diagnostic biomarker in patients with idiopathic pleuroparenchymal fibroelastosis (PPFE).评估尿去甲基精氨酸作为特发性胸膜实质纤维弹性组织增生症(PPFE)患者的一种非侵入性诊断生物标志物。
Respir Med. 2017 Feb;123:63-70. doi: 10.1016/j.rmed.2016.12.013. Epub 2016 Dec 21.
6
Idiopathic pleuroparenchymal fibroelastosis: consideration of a clinicopathological entity in a series of Japanese patients.特发性胸膜肺弹力纤维增生症:日本患者系列中临床病理实体的考虑。
BMC Pulm Med. 2012 Dec 5;12:72. doi: 10.1186/1471-2466-12-72.
7
Body Mass Index and arterial blood oxygenation as prognostic factors in patients with idiopathic pleuroparenchymal fibroelastosis.体重指数和动脉血氧合作为特发性胸膜实质纤维弹性组织增生症患者的预后因素。
Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(1):35-40. doi: 10.36141/svdld.v34i1.5172. Epub 2017 Apr 28.
8
Clinical diagnosis of idiopathic pleuroparenchymal fibroelastosis: A retrospective multicenter study.特发性胸膜肺弹力纤维增生症的临床诊断:一项回顾性多中心研究。
Respir Med. 2017 Dec;133:1-5. doi: 10.1016/j.rmed.2017.11.003. Epub 2017 Nov 6.
9
The pathogenesis and pathology of idiopathic pleuroparenchymal fibroelastosis.特发性胸膜肺实质纤维弹性组织增生症的发病机制与病理
Histol Histopathol. 2021 Mar;36(3):291-303. doi: 10.14670/HH-18-289. Epub 2020 Dec 14.
10
The similarities and differences between pleuroparenchymal fibroelastosis and idiopathic pulmonary fibrosis.特发性肺纤维化与胸膜肺弹力纤维增生症的异同。
Chron Respir Dis. 2019 Jan-Dec;16:1479973119867945. doi: 10.1177/1479973119867945.

引用本文的文献

1
Positive Effects of Nutritional Education in a Patient With Pleuroparenchymal Fibroelastosis.营养教育对一名胸膜实质纤维弹性组织增生症患者的积极影响。
Cureus. 2025 Feb 13;17(2):e78976. doi: 10.7759/cureus.78976. eCollection 2025 Feb.
2
Rare interstitial lung diseases: a narrative review.罕见间质性肺疾病:一篇叙述性综述。
J Thorac Dis. 2024 Sep 30;16(9):6320-6338. doi: 10.21037/jtd-24-450. Epub 2024 Sep 26.
3
The providing multidisciplinary ILD diagnoses (PROMISE) study - study design of the national registry of Japan facilitating interactive online multidisciplinary discussion diagnosis.
提供多学科间ILD 诊断(PROMISE)研究——日本国家注册处的研究设计,促进在线互动多学科讨论诊断
BMC Pulm Med. 2024 Oct 14;24(1):511. doi: 10.1186/s12890-024-03232-1.
4
Proposed Clinical Algorithm for Pleuroparenchymal Fibroelastosis (PPFE).胸膜实质纤维弹性组织增生症(PPFE)的拟用临床算法
J Clin Med. 2024 Jun 24;13(13):3675. doi: 10.3390/jcm13133675.
5
Prognostic value of coexisting conditions and complications in pleuroparenchymal fibroelastosis: a single-center retrospective study.并存疾病及并发症在胸膜实质纤维弹性组织增生症中的预后价值:一项单中心回顾性研究
Sarcoidosis Vasc Diffuse Lung Dis. 2024 Jun 28;41(2):e2024014. doi: 10.36141/svdld.v41i2.13845.
6
Imaging in the diagnosis and management of fibrosing interstitial lung diseases.纤维化间质性肺疾病诊断与管理中的影像学检查
Breathe (Sheff). 2024 Mar;20(1):240006. doi: 10.1183/20734735.0006-2024. Epub 2024 May 14.
7
A Rare Case of Idiopathic Pleuro-Parenchymal Fibroelastosis Presenting With Bilateral Spontaneous Pneumothoraces.一例罕见的特发性胸膜-肺实质纤维弹性组织增生症伴双侧自发性气胸
Cureus. 2024 Mar 26;16(3):e56975. doi: 10.7759/cureus.56975. eCollection 2024 Mar.
8
Multidisciplinary Approach to the Diagnosis of Idiopathic Interstitial Pneumonias: Focus on the Pathologist's Key Role.多学科方法诊断特发性间质性肺炎:关注病理学家的关键作用。
Int J Mol Sci. 2024 Mar 23;25(7):3618. doi: 10.3390/ijms25073618.
9
Three cases of suspected pleuroparenchymal fibroelastosis after allogeneic hematopoietic cell transplantation.三例异基因造血细胞移植后疑似胸膜实质纤维弹性组织增生症的病例。
Blood Cell Ther. 2023 Oct 27;6(4):135-138. doi: 10.31547/bct-2023-018. eCollection 2023 Nov 25.
10
Pulmonary fibroelastosis - A review.肺弹力纤维增生症——综述。
Matrix Biol. 2023 Dec;124:1-7. doi: 10.1016/j.matbio.2023.10.003. Epub 2023 Nov 3.